FDA Inspection 1019450 — bioMerieux Italia SpA
The FDA completed an inspection of bioMerieux Italia SpA on June 15, 2017 in Bagno A Ripoli. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Devices.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- June 15, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Bagno A Ripoli (Italy)